Dr. Edward White Appointed to the Board of Directors of W Technologies, Inc.
W Technologies, Inc. (OTC: WTCG) announced the appointment of Dr. Edward White to its Board of Directors, effective March 8, 2021. Dr. White brings extensive medical expertise, serving as a consultant in Family and Emergency Room practices in Dubai and owning Princeton Medical Solutions. CEO Mikael Lundgren stated that Dr. White's experience will benefit the company as it seeks business opportunities, particularly in the medical CBD sector. The company plans to provide updates on specific opportunities within the next 30 days.
- Dr. Edward White's extensive medical knowledge and experience may enhance the Board's effectiveness.
- The company is actively exploring business opportunities, especially in the medical CBD market, which could lead to growth.
- Concerns about leadership continuity and potential experience gaps with the management change.
BEVERLY HILLS, Calif., March 4, 2021 /PRNewswire/ -- W Technologies, Inc., ("W Tech or the Company"), (OTC:WTCG) announced today that Dr. Edward White will join the Board of Directors, effective on March 8, 2021.
By Dr. White joining our Board, W Technologies will benefit because of his extensive knowledge and experience in the medical field said Mikael Lundgren, CEO of W Tech.
Dr. White currently is a consultant in Family Practice and in Emergency Room Practice at the American Hospital in Dubai and is the owner of Princeton Medical Solutions. Dr. White has also served with the US Army Medical Corp for almost six years. He holds a DEA License for controlled substances.
About W Technologies, Inc.
At this time, the Company's purpose is to seek, investigate and, if such investigation warrants, acquire an interest in business opportunities presented to it by persons or firms who or which desire to seek the perceived advantages of an Exchange Act registered corporation. The Company will not restrict its search to any specific business, industry or geographical location and the Company may participate in a business venture of virtually any kind or nature. This discussion of the proposed business is purposefully general and is not meant to be restrictive of the Company's virtually unlimited discretion to search for and enter into potential business opportunities.
The Company is continuing the review of several opportunities, especially in the field of medical CBD, with the intent to roll up into the Company any situation which results, after extensive review and due diligence, into a signed deal which can be consummated as a roll-up. The Company expects to have more information about specific situations within the next 30 days.
Forward-Looking Statements
Certain statements contained in this press release contain forward-looking statements within the meaning of the U.S. securities laws. Words such as "may," "would," "could," "should," "potential," "will," "seek," "intend," "plan," "anticipate," "believe," "estimate," "expect" and similar expressions as they relate to the Company, are intended to identify forward-looking information. All statements other than statements of historical fact may be forward-looking information. Such statements reflect the Company's current views and intentions with respect to future events, based on information available to the Company, and are subject to certain risks, uncertainties and assumptions. While forward-looking statements are based on data, assumption and analyses that the Company believes are reasonable under the circumstances, whether actual results, performance or developments will meet the Company's expectations and predictions depends on a number of risks and uncertainties that could cause the actual results, performance and financial condition of the Company to differ materially from its expectations. Certain of the "risk factors" that could cause actual results to differ materially from the Company's forward-looking statements, if any, in this press release include, without limitation; general economic, market and business conditions and factors, including the risk factors discussed or referred to in the Company's Form 10 Registration Statement as filed with the U.S. Securities and Exchange Commission and available at www.sec.gov. Should any factor affect the Company in an unexpected manner or should assumptions underlying any such forward-looking information prove incorrect, the actual results or events may differ materially from the results or events predicted. Any such forward-looking information is expressly qualified in its entirety by this cautionary statement. Moreover, the Company does not assume responsibility for the accuracy or completeness of such forward look information. The forward-looking information included in this press release is made as of the date of this press release, and the Company undertakes no obligation to publicly update or revise any forward-looking information, other than as required by applicable law.
CONTACT INFORMATION
W Technologies, Inc.
Mikael Lundgren, CEO
Tel: 424 522 9977
View original content:http://www.prnewswire.com/news-releases/dr-edward-white-appointed-to-the-board-of-directors-of-w-technologies-inc-301240936.html
SOURCE W Technologies
FAQ
Who is Dr. Edward White and what is his role at W Technologies, Inc. (WTCG)?
What are the expected benefits of Dr. White joining the Board of W Technologies, Inc. (WTCG)?
What plans does W Technologies, Inc. (WTCG) have regarding business opportunities?
When did Dr. Edward White join the Board of W Technologies, Inc. (WTCG)?
